AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Scienture Holdings, Inc. Director's Dealing 2021

Jun 4, 2021

35013_dirs_2021-06-04_22569bdc-cdf2-4e2a-9241-322ca0164691.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TRxADE HEALTH, INC (MEDS)
CIK: 0001382574
Period of Report: 2021-05-27

Reporting Person: Jennings Christine L. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct